Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Champlin

Showing results (491-500 of 768) with videos related to

Pageof 77
Sort By:
Cancer|September 3, 2011
A randomized phase 2 trial of a preparative regimen of bortezomib, high-dose melphalan, arsenic trioxide, and ascorbic acidManish Sharma, Hassan Khan, Peter F Thall, et al.
The New England Journal of Medicine|November 27, 2004
Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemiaMary J Laughlin, Mary Eapen, Pablo Rubinstein, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
Lovastatin inhibits T-cell proliferation while preserving the cytolytic function of EBV, CMV, and MART-1-specific CTLsDan Li, Yufeng Li, Jessica A Hernandez, et al.
Molecular Imaging and Biology|June 2, 2016
Imaging of Sleeping Beauty-Modified CD19-Specific T Cells Expressing HSV1-Thymidine Kinase by Positron Emission TomographyAmer M Najjar, Pallavi R Manuri, Simon Olivares, et al.
Haematologica|January 16, 2009
Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignanciesCarlos A Ramos, Rima M Saliba, Leandro de Pádua, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2014
Activating and propagating polyclonal gamma delta T cells with broad specificity for malignanciesDrew C Deniger, Sourindra N Maiti, Tiejuan Mi, et al.
Leukemia & Lymphoma|December 3, 2011
Donor leukocyte infusions in recurrent Hodgkin lymphoma following allogeneic stem cell transplant: 10-year experience at the M. D. Anderson Cancer CenterPaolo Anderlini, Rima Saliba, Sandra Acholonu, et al.
Leukemia|October 3, 2008
PET imaging of T cells derived from umbilical cord bloodH Singh, A M Najjar, S Olivares, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 20, 2014
The effect of peritransplant minimal residual disease in adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantationYi Zhou, Rebecca Slack, Jeffrey L Jorgensen, et al.
Haematologica|August 20, 2016
Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemiaBetül Oran, Jeff L Jorgensen, David Marin, et al.
Pageof 77

Showing results (491-500 of 768) with videos related to

Sort By:
Pageof 77
Cancer|September 3, 2011
A randomized phase 2 trial of a preparative regimen of bortezomib, high-dose melphalan, arsenic trioxide, and ascorbic acidManish Sharma, Hassan Khan, Peter F Thall, et al.
The New England Journal of Medicine|November 27, 2004
Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemiaMary J Laughlin, Mary Eapen, Pablo Rubinstein, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
Lovastatin inhibits T-cell proliferation while preserving the cytolytic function of EBV, CMV, and MART-1-specific CTLsDan Li, Yufeng Li, Jessica A Hernandez, et al.
Molecular Imaging and Biology|June 2, 2016
Imaging of Sleeping Beauty-Modified CD19-Specific T Cells Expressing HSV1-Thymidine Kinase by Positron Emission TomographyAmer M Najjar, Pallavi R Manuri, Simon Olivares, et al.
Haematologica|January 16, 2009
Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignanciesCarlos A Ramos, Rima M Saliba, Leandro de Pádua, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2014
Activating and propagating polyclonal gamma delta T cells with broad specificity for malignanciesDrew C Deniger, Sourindra N Maiti, Tiejuan Mi, et al.
Leukemia & Lymphoma|December 3, 2011
Donor leukocyte infusions in recurrent Hodgkin lymphoma following allogeneic stem cell transplant: 10-year experience at the M. D. Anderson Cancer CenterPaolo Anderlini, Rima Saliba, Sandra Acholonu, et al.
Leukemia|October 3, 2008
PET imaging of T cells derived from umbilical cord bloodH Singh, A M Najjar, S Olivares, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 20, 2014
The effect of peritransplant minimal residual disease in adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantationYi Zhou, Rebecca Slack, Jeffrey L Jorgensen, et al.
Haematologica|August 20, 2016
Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemiaBetül Oran, Jeff L Jorgensen, David Marin, et al.
Pageof 77